Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Avai Bio (AVAI) Depreciation & Amortization (IS) (2018 - 2025)

Avai Bio's Depreciation & Amortization (IS) history spans 6 years, with the latest figure at $47267.0 for Q1 2024.

  • On a quarterly basis, Depreciation & Amortization (IS) rose 1136.06% to $47267.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $76952.0, a 228.63% increase, with the full-year FY2025 number at $74320.0, down 3.42% from a year prior.
  • Depreciation & Amortization (IS) hit $47267.0 in Q1 2024 for Avai Bio, up from $10267.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for AVAI hit a ceiling of $47267.0 in Q1 2024 and a floor of $3824.0 in Q1 2023.
  • Historically, Depreciation & Amortization (IS) has averaged $13492.4 across 4 years, with a median of $11129.5 in 2022.
  • Biggest five-year swings in Depreciation & Amortization (IS): surged 19178.67% in 2020 and later dropped 23.79% in 2023.
  • Tracing AVAI's Depreciation & Amortization (IS) over 4 years: stood at $14124.0 in 2020, then plummeted by 72.92% to $3825.0 in 2022, then skyrocketed by 168.42% to $10267.0 in 2023, then surged by 360.38% to $47267.0 in 2024.
  • Business Quant data shows Depreciation & Amortization (IS) for AVAI at $47267.0 in Q1 2024, $10267.0 in Q4 2023, and $10317.0 in Q3 2023.